License Demeetra’s Gene Editing Tools

Our true north is simple and accessible licenses to commercial users. Demeetra recognizes the value our gene editing tools can have to biotech companies and to the world. We have commercial freedom to operate in our fields of use and look forward to hearing how our technology can help you and your project goals.



  • Flexible 6-month period
  • Evaluation fee, which includes the cost of reagents
  • Expert tech support and protocols

Commercial License

  • Flexibility of one-time fee-based license or more standard royalty structure
  • Freedom to operate
  • Own the IP you developed using our technology

We also encourage collaborations with academic groups focused on applying our gene editing technologies in their unique systems for later commercialization.

We Enable Researchers And Companies To Obtain More With Less Inconvenience

Contact us to learn more about our gene editing technology.